Advertisement

Product › Details
drug development
![]() |
Next higher product group | drug discovery |
Record changed: 2022-04-17 |
Advertisement
![Picture [iito] Fighting Customers 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-fighting-customers.jpg)
More documents for drug development
- [1] SciRhom GmbH. (5/12/22). "Press Release: SciRhom Announces Addition to the Management Team". Munich....
- [2] Hovione. (5/9/22). "Press Release: Hovione and Jixing Announce an Exclusive Global License Agreement for Ophthalmology Program". Lisbon & Shanghai....
- [3] ReViral Ltd.. (4/7/22). "Press Release: Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates". New York, NY, London & Research Triangle Park, NC....
- [4] Novartis AG. (4/4/22). "Press Release (Ad hoc): Novartis Announces New Organizational Structure to Accelerate Growth, Strengthen Pipeline and Increase Productivity". Basel....
- [5] Sanofi S.A.. (3/16/22). "Press Release: Sanofi and Seagen Announce Collaboration to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates". Paris....
- [6] MorphoSys AG. (3/10/22). "Press Release (Ad hoc): MorphoSys AG Reports Non-cash Impairment Charge of approx. € 231 Million on Goodwill after Consolidation of Research and Discovery Functions, Corresponding Increase of Group Operating Expenses in 2021". P...
- [7] Aelis Farma S.A.. (2/15/22). "Press Release: Aelis Farma, a Biopharmaceutical Company Developing a New Generation of Drugs for Brain Diseases, Announces the Success of Its Initial Public Offering and Raises approximately €25 Million on Euronext Paris [No...
- [8] AMR Action Fund. (2/7/22). "Press Release: AMR Action Fund Opens European Office". Boston, MA....
- [9] Evotec SE. (2/4/22). "Press Release: Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to All P2X3 Assets [Ad hoc release]". Hamburg....
- [10] Roche. (2/1/22). "Press Release: Changes to the Roche Board of Directors and the Corporate Executive Committee". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top